Real-world outcomes associated with letermovir use for cytomegalovirus (CMV) primary prophylaxis in allogeneic-hematopoietic cell transplant recipients: a systematic review and meta-analysis of observational studies

被引：0
|
作者：
Raval, A. [1 ]
Kamat, S. [2 ]
Vyas, A. [2 ]
Tang, Y. [1 ]
LaPlante, K. [2 ]
Chemaly, R. [3 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Univ Rhode Isl, Kingston, RI 02881 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O089
引用
收藏
页码：59 / 60
页数：2
相关论文
共 50 条
  • [1] Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies
    Vyas, Ami
    Raval, Amit D.
    Kamat, Shweta
    LaPlante, Kerry
    Tang, Yuexin
    Chemaly, Roy F.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (01):
  • [2] Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience
    Lin, Andrew
    Maloy, Molly
    Su, Yiqi
    Bhatt, Valkal
    DeRespiris, Lauren
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony
    Barker, Juliet
    Shaffer, Brian
    Giralt, Sergio A.
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Papanicolaou, Genovefa A.
    Seo, Susan K.
    Perales, Miguel-Angel
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [3] Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review
    Sepassi, Aryana
    Saunders, Ila M.
    Bounthavong, Mark
    Taplitz, Randy A.
    Logan, Cathy
    Watanabe, Jonathan H.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (04) : 1138 - 1149
  • [4] Clinical "Real-World" Experience with Letermovir for Prevention of Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplant Recipients
    Anderson, Anthony D.
    Raja, Mohammed
    Morris, Michele I.
    Komanduri, Krishna V.
    Camargo, Jose F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S317 - S318
  • [5] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93
  • [6] Clinical "real-world" experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients
    Anderson, Anthony
    Raja, Mohammed
    Vazquez, Neisy
    Morris, Michele
    Komanduri, Krishna
    Camargo, Jose
    CLINICAL TRANSPLANTATION, 2020, 34 (07)
  • [7] CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [8] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [9] EFFECTIVENESS OF LETERMOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN SEROPOSITIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A GLOBAL SYSTEMATIC REVIEW
    Sepassi, A.
    Saunders, I
    Bounthavong, M.
    Watanabe, J.
    VALUE IN HEALTH, 2022, 25 (07) : S322 - S322
  • [10] Real World Outcomes of Letermovir Prophylaxis in Unselected High Risk CMV Seropositive Hematopoietic Stem Cell Transplant Recipients
    Karam, Eva
    LaPorte, Justin
    Sizemore, Connie
    Zhang, Xu
    Holland, H. Kent
    Solh, Melhem
    Morris, Lawrence E.
    Bashey, Asad
    Solomon, Scott R.
    BLOOD, 2019, 134
12345